Clinical Trial Update: TAF Switch Study in Hepatitis B Monoinfection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describing a switch to tenofovir alafenamide (TAF) for hepatitis B monoinfection. The sponsor is the Asian Pacific Liver Center …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Asian Pacific Liver Center at Coalition of Inclusive Medicine | Conditions: Hepatitis B | Phase 4 | Status: UNKNOWN